A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection
Study description
This study seeks to evaluate the efficacy and safety of ABT-493/ABT-530 in participants with Genotype 1 hepatitis C virus infection without cirrhosis
Pathology
Hepatitis C Virus HCV
Study type
Clinical trial
Status
Terminated
Study start date
2015
Study completion date
2017
Funder Type
Industry funded study
Investigator
Dr. med. Lorenzo MAGENTA
Recruitment
Completed